research article
Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2: Overview 2019
Abstract
Review on the group of myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2 defined by the WHO 2016- Article
- eosinophilia
- PDGFRA
- PDGFRB
- FGFR1
- PCM1/JAK2
- Leukaemia Section
- Biomarkers, Tumor/*genetics
- Bone Marrow Cells/metabolism/pathology
- Chromosomes, Human, Pair 2/genetics
- Chromosomes, Human, Pair 5/genetics
- Golgi Matrix Proteins/*genetics
- Humans
- Hypereosinophilic Syndrome/*genetics/pathology
- Leukemia/*genetics/pathology
- Male
- Middle Aged
- Oncogene Fusion
- Oncogene Proteins, Fusion/*genetics
- Receptor, Platelet-Derived Growth Factor beta/*genetics
- Translocation, Genetic
- Blood Cell Count
- Chromosomes, Human, Pair 5/genetics
- Chromosomes, Human, Pair 9/genetics
- Humans
- Hypereosinophilic Syndrome/blood/drug therapy/*genetics
- Imatinib Mesylate/therapeutic use
- Leukemia/blood/drug therapy/*genetics
Similar works
This paper was published in I-Revues.
Having an issue?
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.